[1]
“Formulation and Evaluation of Gastroretentive Dosage Form of Ofloxacin”, S.J. Pharm. Sci, vol. 4, no. 1, pp. 9–18, Nov. 2011, doi: 10.3329/sjps.v4i1.8861.